Published Jun 22, 2026, 1:23 PM ET · Updated 5 months ago · 1 source
Psychedelic Drugmaker Definium Surges on Depression Drug Success
bloomberg
·
Original Report
INFERY
Definium Therapeutics Inc. shares rally as much as 60% Monday after late-stage trial data showed “groundbreaking” results in the psychedelic drug developer’s experimental treatment for major depressive disorders.